Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum-Reference-Cited by-同舟云学术

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum

Published:2020-06-23 Issue:10 Volume:16 Page:1358-1371
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Milà‐Alomà Marta¹²³⁴,Salvadó Gemma¹²,Gispert Juan Domingo¹²³⁵,Vilor‐Tejedor Natalia¹³⁶⁷,Grau‐Rivera Oriol¹²⁴⁸,Sala‐Vila Aleix¹²,Sánchez‐Benavides Gonzalo¹²⁴,Arenaza‐Urquijo Eider M.¹²⁴,Crous‐Bou Marta¹²⁴⁹,González‐de‐Echávarri José Maria¹²,Minguillon Carolina¹²⁴,Fauria Karine¹⁴,Simon Maryline¹⁰,Kollmorgen Gwendlyn¹¹,Zetterberg Henrik¹²¹³¹⁴¹⁵,Blennow Kaj¹²¹³,Suárez‐Calvet Marc¹²⁴⁸,Molinuevo José Luis¹²³⁴,

Affiliation:

1. Barcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain

2. IMIM (Hospital del Mar Medical Research Institute) Barcelona Spain

3. Universitat Pompeu Fabra Barcelona Spain

4. Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES) Madrid Spain

5. Centro de Investigación Biomédica en Red Bioingeniería Biomateriales y Nanomedicina Madrid Spain

6. Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology Barcelona Spain

7. Department of Clinical Genetics ERASMUS MC Rotterdam the Netherlands

8. Servei de Neurologia Hospital del Mar Barcelona Spain

9. Department of Epidemiology Harvard T.H. Chan School of Public Health Boston Massachusetts USA

10. Roche Diagnostics International Ltd Rotkreuz Switzerland

11. Roche Diagnostics GmbH Penzberg Germany

12. Department of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology University of Gothenburg Mölndal Sweden

13. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

14. Department of Neurodegenerative Disease UCL Institute of Neurology Queen Square London United Kingdom

15. UK Dementia Research Institute at UCL London United Kingdom

Funder

“la Caixa” Foundation

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12131

Reference51 articles.

1. Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease

2. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

3. Biomarker Modeling of Alzheimer’s Disease

4. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

5. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment;CNS & Neurological Disorders - Drug Targets;2024-12

2. Polygenic hazard score predicts synaptic and axonal degeneration and cognitive decline in Alzheimer's disease continuum;Archives of Gerontology and Geriatrics;2024-12

3. Neuroinflammation, cerebrovascular dysfunction and diurnal cortisol biomarkers in a memory clinic cohort: Findings from the Co-STAR study;Translational Psychiatry;2024-09-09

4. Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer’s disease and a history of traumatic brain injury;Neurobiology of Aging;2024-09

5. The impact of physical exercise on neuroinflammation mechanism in Alzheimer’s disease;Frontiers in Aging Neuroscience;2024-08-21